Načítá se...
In the beginning and at the end: calreticulin
In this issue of Blood, Theocharides et al report one of likely many functionally important untoward consequences of mutant calreticulin that may arise in the clinical context of myelofibrosis.(1) Even when viewed through the narrow prism of neutrophil biology, mutant calreticulin will adversely aff...
Uloženo v:
| Vydáno v: | Blood |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Hematology
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4920016/ https://ncbi.nlm.nih.gov/pubmed/27340251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-04-708198 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|